Leadhexa Biotechnologies is Biotechnology in United States that focus on ischemia-reperfusion injury business. Founded in 2014. They cover business area such as developer, molecular technology, enzyme Manganese Superoxide Dismutase, efficacy, numerous preclinical model, actinic keratosis, radiation protection, kidney damage, cyclosporine, liver cirrhosis, ischemia-reperfusion injury, doctor, supra-stoichiometric amount, reactive oxygen specie, cell.
2014
( 10 years old in 2024 )
Ischemia-reperfusion Injury
-
953 Indiana Street
San Francisco, CA
United States
Private
developermolecular technologyenzyme Manganese Superoxide Dismutaseefficacynumerous preclinical modelactinic keratosisradiation protectionkidney damagecyclosporineliver cirrhosisischemia-reperfusion injurydoctorsupra-stoichiometric amountreactive oxygen speciecell
* We use standard office opening hours in near Leadhexa Biotechnologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Leadhexa Biotechnologies is Biotechnology business from United States that founded in 2014 (10 years old in 2024), Leadhexa Biotechnologies business is focusing on Ischemia-reperfusion Injury.
Leadhexa Biotechnologies headquarter office and corporate office address is located in 953 Indiana Street San Francisco, CA United States.
Leadhexa Biotechnologies was founded in United States.
In 2024, Leadhexa Biotechnologies is currently focus on ischemia-reperfusion injury sector.
Above is snippet of Google Trends for "ischemia-reperfusion injury" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Leadhexa Biotechnologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
